Shuxuan Li , Ke Ma , Yujie Zhao , Luning Zhou , Peng Zhang , Hanwei Liu , Yajin Ye , Wenhan Lin , Jaclyn M. Winter , Guangwei Wu
{"title":"Genome mining and characterization of bifunctional Clerodane Diterpene synthase from a fungus Myrothecium sp","authors":"Shuxuan Li , Ke Ma , Yujie Zhao , Luning Zhou , Peng Zhang , Hanwei Liu , Yajin Ye , Wenhan Lin , Jaclyn M. Winter , Guangwei Wu","doi":"10.1016/j.bioorg.2025.108548","DOIUrl":null,"url":null,"abstract":"<div><div>Clerodane diterpenoids are a promising group of pharmacological molecules and are rarely discovered in fungi. The clerodane diterpene synthase has not yet been characterized in fungi. Herein, we discovered a gene, <em>mterA</em>, encoding chimeric protein with the bifunction of class II and class I synthases from a fungus <em>Myrothecium</em> sp. by genome mining. Heterologous co-expression of <em>mterA</em> and <em>mterB</em> in engineered yeast led to the production of a clerodane diterpene product (5<em>S</em>, 8<em>R</em>, 9<em>R</em>, 10<em>S</em>)-terpentetriene (<strong>1</strong>), confirming the existence of a fungi-derived special clerodane diterpene synthase. Site-directed mutagenesis on conserved motifs revealed a strong influence on terpentetriene accumulation. Gene inactivation of <em>mterA</em> indicated that the <em>mter</em> gene cluster was likely cryptic or weakly expressed in the host under the laboratory conditions. Compound <strong>1</strong> exhibited significant inhibitory activity against the plant pathogen <em>Bacillus subtilis</em> with a MIC value of 8 μg/mL and activated the plant immune response. MterA representes the first chimeric bifunctional clerodane diterpene synthase.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"161 ","pages":"Article 108548"},"PeriodicalIF":4.5000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825004286","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Clerodane diterpenoids are a promising group of pharmacological molecules and are rarely discovered in fungi. The clerodane diterpene synthase has not yet been characterized in fungi. Herein, we discovered a gene, mterA, encoding chimeric protein with the bifunction of class II and class I synthases from a fungus Myrothecium sp. by genome mining. Heterologous co-expression of mterA and mterB in engineered yeast led to the production of a clerodane diterpene product (5S, 8R, 9R, 10S)-terpentetriene (1), confirming the existence of a fungi-derived special clerodane diterpene synthase. Site-directed mutagenesis on conserved motifs revealed a strong influence on terpentetriene accumulation. Gene inactivation of mterA indicated that the mter gene cluster was likely cryptic or weakly expressed in the host under the laboratory conditions. Compound 1 exhibited significant inhibitory activity against the plant pathogen Bacillus subtilis with a MIC value of 8 μg/mL and activated the plant immune response. MterA representes the first chimeric bifunctional clerodane diterpene synthase.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.